Neogenomics, Inc.
NEO
$12.07
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.57% | 7.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.57% | 7.91% | |||
| Cost of Revenue | 2.76% | 10.22% | |||
| Gross Profit | 4.67% | 4.93% | |||
| SG&A Expenses | -4.83% | 0.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.91% | 4.59% | |||
| Operating Income | 35.42% | 15.45% | |||
| Income Before Tax | 42.40% | -78.57% | |||
| Income Tax Expenses | 202.21% | -372.18% | |||
| Earnings from Continuing Operations | 39.84% | -73.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.84% | -73.95% | |||
| EBIT | 35.42% | 15.45% | |||
| EBITDA | 119.85% | 37.97% | |||
| EPS Basic | 40.04% | -73.17% | |||
| Normalized Basic EPS | 33.18% | 15.73% | |||
| EPS Diluted | 40.04% | -73.17% | |||
| Normalized Diluted EPS | 33.18% | 15.73% | |||
| Average Basic Shares Outstanding | 0.36% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||